What's the Difference? Biosimilar and Generic Drugs
Generic Medicine

What’s the Difference? Biosimilar and Generic Drugs

The primary issue with biosimilar drugs is that numerous doctors and patients cannot distinguish them from generic drugs. They tend to believe that both are just copies of the original or reference drug.

In fact, the survey created by PwC in December 2015 states that around 67% of consumers were not sure what a biosimilar was, and about 16% gave an incorrect answer to the question about what a biosimilar was.

Although both generic drugs and biosimilars have the same commercial basis, meaning they are marketed when the original drug’s patent has expired, they are two completely different products regarding their structure, development, and authorization. In this article, we’ll discuss the main differences between biosimilars and generic drugs as per leading generic medicine suppliers.

What Are Generics?

A generic drug is a type of medicine that contains the same API and has an equivalent therapeutic effect as the branded drug. These drugs are additionally identical in terms of safety, dosage, strength, quality, route of administration, intended use, form, quality, effect, and side effects. These drugs can be manufactured just after the branded drug’s patent expiration.

Many reputed generic pharma companies in India use some simple chemical structures that can be manufactured quickly as compared to biosimilars.

What Are Biosimilar Drugs?

A biosimilar is a biologic medical product that is highly similar to already certified biological drugs. They get approval as per the pharma quality, safety, and effectiveness standards apply to all biological medicines.

Just like generics, biosimilars products can’t be manufactured until the patent of the drug expires. Due to the natural variability and complex processing of biological drugs don’t permit duplication of the molecular micro-heterogeneity. Thus, a biosimilar isn’t regarded as a generic of biological medicine.

Difference Between the Biosimilar and Generic Drugs

Although both generic and biosimilars medicines have similar revenue goals and are only permitted to market when the original drug’s patent has expired, they are entirely different products when it comes to their development, structure, and authorization.

Here are a couple of main differences between generic and biosimilars drugs.

  • Biologic medicines are large and complicated molecules or compounds of molecules that may be formed of living material, while generic drugs are chemically synthesized.
  • Unlike generic drugs, the FDA demands a biosimilar to be highly similar but not very identical to the current biologic medicine or the reference product.
  • A biosimilar medicine should demonstrate no clinically meaningful differences in safety, efficacy, and potency with its reference product. It must be the same as the original biological medicine, while the generics are branded products.
  • The generic drug’s cost usually reaches 40% to 50% less than the branded products and biosimilars. On the other hand, it is more like 15% to 20% cheaper due to the generic pharmaceutical manufacturer’s cost of testing.
  • It is easy to create accurate generics copies of branded drugs, plus it requires no complicated modifications, making the drug manufacturing process smooth.
  • Like generic drugs, biosimilars and other reference drugs aren’t synthesized through an easy chemical synthetic reaction. They require a complicated process in a cellular environment, such as any protein from the body.
  • Almost all generic drugs require an investment of around 2-3 million dollars, but due to the complexity involved, biosimilars need an investment of around 3+ billion dollars.
  • Generic drugs can reach your desired market in 2 to 3 years, but a biosimilar drug needs approximately between 7 and 8 years to reach the market. This extended timeline for biosimilars is due to the numerous studies necessary for their authorization, including safety and efficacy studies compared to reference branded drugs.
  • Generic drugs must have bioequivalence studies in healthy volunteers but do not need preclinical studies. When it is marketed, they need the proper pharmacovigilance process.
  • Unlike generics, biosimilars are evaluated and certified under the FDA evaluation process called 351(k) pathway 2.

Why Are Organizations Looking for Generic and Biosimilar Markets?

The increasing danger of chronic diseases such as diabetes & cardiovascular diseases, the large geriatric population, increasing healthcare expenses contribute to the growth of the generic drug market and an increased number of branded drug patent expires.

Being a leading generic pharma company in India, we, at JoinHub Pharma, think of the other key factors such as:

  • Stringent governmental regulations and adverse effects linked with new drug development.
  • The increasing demand for newer versions of generic drugs
  • Many licensing and procedural strategies require to launch of new products by companies
  • In contrast with branded drugs, the generic drug’s manufacturing costs much less since they don’t need animal studies and clinical trials to show the efficacy and safety of the drug.
  • Due to the lowered upfront cost incurred in R&D, generics are usually marketed at a considerably lower price.

Investment and Cost of Development: Generic Vs. Biosimilar

Generally, generic drugs cost 40% to 50% less than the branded drug. On the other hand, Biosimilars are nearly 15% to 20% cheaper due to the generic pharmaceutical companies’ expense on testing.

Generic drugs need an investment of around 2-3 million dollars. However, biosimilars need a considerable investment of around 3 billion dollars due to the given complexity. Moreover, while a generic drug can touch the market within an approximate period of 2 to 3 years, a biosimilar drug requires between 7 and 8 years in order to be marketed. All this time required to develop biosimilars is due to the numerous studies necessary for their authorization, including pharmacokinetic studies.

JoinHub Pharma – The key Market Player

JoinHub Pharma is the biggest generic pharmaceutical company. The company is certified by the highest authority like WHO-GMP, EUGMP, FDA, MOH, etc. They are ranked in the top 10 generic pharmaceuticals companies in India and are known for high-quality pharma manufacturing products and services.

Get in touch with the experts at JoinHub Pharma today to know more about manufacturing generic and biosimilar drugs.

You may also like to read these blogs:-

Importance and Amazing Benefits of Generic Drugs

Importance and Amazing Benefits of Generic Drugs
Generic Medicine

Importance and Amazing Benefits of Generic Drugs

The high price often associated with prescription drugs can make it hard to comply with a doctor’s directives for some patients. Many health conditions demand patients stay on a prescribed drug in order to decrease the cruelty of symptoms or live with minor discomfort.

When expenses are an obstacle to the constant usage of specific medications, patients should learn more about generic drug options rather than abandoning their prescriptions. Those who use generic drugs are in the great company since generic drugs match around 90% of prescriptions filled in the United States.

As drug research is costly since the payments of the study, the pioneer determines the price for the drug, which is actually high and at least not affordable by the ordinary man. For this reason, generic drugs are introduced by a generic pharma company in India.

Why Are Generic Drugs Import

ant?

A generic drug is a pharma medicine equal to a brand-name product in strength, dosage, kinetics, way of treatment, quality, and its intended usage. It may additionally refer to any drug, which is promoted under its chemical name without advertising.

For approval to promote the standard drug, an abbreviated new drug application known as ANDA is to be submitted by the generic pharmaceutical companies.

High-quality generic drugs are essential since they are less expensive choices to their brand-name alternatives. The high usage and easy accessibility of generic drugs of branded medicines have an actual result in saving expenses for health care users.

Although generics are demanded to fill most medications, the actual costs connected with these prescriptions are less when compared to branded counterparts. Generic Drug Development is uniquely established to FDA safety assessments, post-marketing needs, and Pharmacovigilance efforts to help assure the sustained capability of the expert category.

Benefits of Generic Drugs:-

 

Patients Can Save Serious Money with Generic

How can this be? As per the FDA, generic drugs can cost are estimated about 85% less expensive than medicines designed to counterfeit. The studies show that branded drugs don’t have to be repeated with their bioequivalent generic replacement, assisting in cutting their cost dramatically.

Generic Drugs Can Be Just as Effective as alternate Branded drugs.

Generic drugs offered by a reputed generic medicine supplier are an efficacious and FDA-approved option for patients. Such medicines are identical to their brand-name equivalent in numerous categories, including dosage, strength, form, safety, quality, intended use, and performance properties. Thus, the generic drug is considered to be bioequivalent.

Patients Can Easily Find a Generic Equivalent

Patients do not want to investigate far to see alternatives to many popular branded drugs. There are many common medications with high-quality generic equivalents, as above 12,000 generic drugs are readily available to customers. For example, the allergy medication named Allegra can be exchanged with Fexofenadine. Warfarin can replace another famous blood-thinning drug called Coumadinrin.

Generic Drugs Help can Reduce Costs in the U.S. Health Care System

It is not only patients who benefit from high-quality generic drugs. Association for Approachable Medicines shared that in the past 10 years, the savings for the U.S. healthcare system from generic drugs is around $1.67 trillion.

As healthcare expenditures continue to increase, it is essential to contact the best generic pharmaceutical manufacturers for alternatives and make them readily available to patients. This may slow down the increase in health care expenses often passed along to patients.

Stay the Course with Generics

Patients are 3x times more likely to abandon branded prescriptions than their generic alternatives, and this abandonment is often directly related to high copays.

Generic drugs are an easy and affordable alternative for treating several people who have to take prescription drugs. They can increase the probability that patients follow through with doctor-recommended care.

Contact JoinHub Pharma – the biggest generic pharmaceutical company in India for placing bulk orders of generic drugs.

You may also like to read these blogs:-

Top 5 Indian Generic Medicine Suppliers in Latin America

Top 5 Indian Generic Medicine Suppliers in Latin America
Generic Medicine

Top 5 Indian Generic Medicine Suppliers in Latin America

The demand for generic Medicine / Drugs is increasing in Latin America, and Indian pharmaceutical companies realize this opportunity’s great potential. Efficient and affordable medicines are always required, making this a flourishing market for drugmakers.

The worldwide generic drugs market is forecasted to increase at a compound annual growth rate (CAGR) of 8.7%, meaning that, in the projection period 2016 to 2021, the worldwide market will rise from almost $352 billion to $533 billion.

In this article, the top five Indian generic pharmaceuticals suppliers, manufacturers and distributors are listed:

JoinHub Pharma

JoinHub Pharma is an award-winning Pharmaceutical Company in India. We hold a reputed name with regards to branded medicines and generic medicines. Our company is certified by the highest authority like WHO, FDA, ISO 9001:2008, GMP, etc. We are a top generic pharma manufacturer, supplier, and distributor in Latin America and are known for our top-of-the-line quality pharma products and services. Without a doubt, we are considered to be one of the best generic pharmaceutical companies in India.

In fact, 85% of our revenue is generated by way of exporting to MIDDLE EAST, CIS, and AFRICA production facilities. We are famous for our widest list of medicines which contains more than 1000+ pharma products.

Based in India, JoinHub Pharma is a generic pharma company in India with a broad footprint covering the US, Europe, South-East Asia, Middle East, and South Africa. It manufactures more than 200 generic drugs and complex APIs in a wide range of therapeutic areas, including cardiovascular, diabetes, HIV, oncology, infectious diseases, hepatitis, ophthalmology, urology, neurosciences, respiratory, and women’s health.

Dr. Reddy

The global generics segment of Dr. Reddy’s accounted for approximately 80% of the company’s revenue in 2018, with North America being the biggest contributor.

As of March 2018, the company filed 20 abbreviated new drug applications (ANDAs) and had 110 generic filings pending approval with the US FDA. Moreover, it launched five first-generic-to-launch (FGTL) products in Brazil.

Based in India, Dr. Reddy’s is an Indian pharmaceutical company whose generic formulations business offers more than 200 high-quality generic medicines worldwide, with over 20 assets falling under the complex generics category, including decitabine, fondaparinux, and azacitidine injections.

The company’s generic formulations segment includes tablets, capsules, injectables, and topical creams. Nise (Nimesulide), Stamlo (Amlodipine Besylate), Omez (Omeprazole), and Razo (Rabeprazole) are a couple of its products available in Latin America’s emerging markets.

Teva Pharmaceutical

Teva Pharmaceuticals’ 2018 revenues in North America decreased by 22% as compared to 2017 because of the price erosion and volume reductions. They have launched generic versions of medicines such as Solodyn®, Aloxi®, Syprine®, Estrace®, Lialda®, Uceris®, and Elidel® in the region in 2018.

The company’s European revenues increased by 4% to $3.6bn, compared to 2017. The revenue growth resulted from an increase in OTC medicine sales and the launch of new pharma products, which offset the impact of price cuts of generics in the first half of 2018. However, the overall revenue was affected marginally in the second half of 2018 because of the dismissal of Teva’s joint venture with PGT Healthcare.

Teva Pharmaceuticals offers diverse products in various segments such as specialty, generic, OTC, and APIs.

Cipla

Cipla’s revenues progressed marginally compared to the earlier year, with the generics business in Latin America contributing around 21% to the domestic business revenues as of March 2018.

The company was ranked as one of the top ten generic Pharma manufacturers in the US, with 13 out of 52 products ranked as number one, according to IQVIA IMS RQTR as of March 2018.

Cipla is working to develop complex generic formulations based on nanotechnology for the US market.

Lupin

Lupin’s generics business held 90% of the company’s total revenues in the US in 2018. It was established in 1968, and while its primary focus is generic drugs, it additionally produces branded medicines and API (active pharmaceutical ingredients).

Lupin filed 20 generic products in many geographic regions worldwide, which includes the APAC (Japan & Australia), Canada, EMEA (Europe, Middle East, and Africa), and Latin America (Brazil & Mexico), and got 22 approvals in 2018.

Lupin also got 24 ANDA approvals out of 36 ANDA files in the US in 2018.

Lupin is a pharma company based in India with many segments, including generic products, biotechnology products, complex generics, APIs, and specialty.

If you’re looking for generic medicines at an affordable rate, contact JoinHub Pharma – a leading generic pharma company in India.

Simply drop them an email at [email protected] or call directly on +91 97247 25604.

 

You may also like to read these blogs:-

Best Generic Medicine Pharmaceutical Manufacturer, Supplier & Exporters in Latin America
Generic Medicine

Best Generic Medicine Pharmaceutical Manufacturer, Supplier & Exporters in Latin America

Nowadays, as diseases are increasing at a fast rate, so is the need for a Global supplier of pharmaceuticals and drugs in the USA along with the Indian pharmaceuticals providers in the USA as they are cheap and affordable.

When we talk about global distributors and suppliers of pharmaceuticals drugs, India is definitely a country that ranked at the top of the list. India is one of the largest cardiology medicine exporters in the US and distributors to Latin America.

What is the Generic Pharmaceutical Manufacturing Industry in Latin America?

Generic medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Many generic drugs are manufactured, distributed, and supplied without patent protection, and industry operators are not even engaged in the R&D of new drugs.

The pharma industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

Which Are The Top Generic Pharma Companies In India?

The pharma companies holding the largest market share in the Generic Pharmaceutical Manufacturing in the US industry include JoinHub Pharma.

JoinHub Pharma is a leading generic pharmaceutical manufacturer, supplier, exporter in Latin America and offering services to pharmacies across the US. Now, you can streamline your pharma medicine purchasing and optimized your buying power by utilizing the comprehensive purchasing strategy offered by JoinHub Pharma. We manufacture, we deliver, and you save.

We are highly committed to making our pharma company your first and last call when you have a need for medicine export from India. You will find us valuable, friendly, and efficient for all your pharma needs.

Branded & Generic Medicine Distribution

JoinHub Pharma has a wide range of 10,000+ generic and branded medicines’ manufacturing and distribution services across India and is one of the top generic medicine distributors in Latin America, South Africa, and the Middle East.  As a leading branded and generic medicine manufacturer and supplier in Latin America, we deal in all sorts of medicines, i.e., liquid, capsules, topical medicines, inhalers, tablets, suppositories, injections, implants or patches, buccal, drops, etc.

JoinHub Pharma provides branded and generic medicine distribution with national coverage across the country.

JoinHub Pharma offers its clients up-to-date pricing, inventory levels, and order status (hospitals, dispensaries, patients, pharmacies). With JoinHub Pharma, clients have access to:

  • Direct reach to 10,000+ branded & generic medical & health care products
  • Up-to-date branded & generic medicines and their reasonable pricing information
  • Simplified, intuitive, branded & generic medicine ordering
  • Branded & generic medicine manufacturing and distribution purchase history with detailed reporting

Our product as pharma Exporter India range includes HIV medicines, oncology, and other lifesaving generic medicines.

What We Offer You as Generic Medicine Manufacturer and Distributor?

JoinHub Pharmaceuticals has developed around 400 molecules that are being utilized in making around 1000 dosage combinations to prepare the generic medicine. We cover a wide range of healthcare products like derma, pediatric, cancer, fluid therapy, etc.

We use the latest packaging technology to ensure high-quality and cost-effective generic medicines. Our generic medicines are manufactured and supply under the following categories:

  • Tablets
  • Injections
  • Capsules
  • Ointment
  • Sachets
  • Powders
  • Syrups
  • Lotions

Our medicine manufacturing process occurs in WHO and GMP-certified pharmaceutical plants that are well-equipped with ultra-modern systems and machinery. Every single drug manufacturing step is carried out with 100% accuracy and precision by measuring the composition. Thus, you can be assured of getting the most genuine generics if you choose us as generic medicine exporters.

Our Role as Generic Medicine Suppliers in Latin America

Busy and fast modern lives give rise to a lot of health issues. These include headaches, body aches, colds, vitamin deficiency, and low energy levels. Apart from the common problems, life-threatening ailments like Cancer and HIV-AIDS are at their peak. The branded medicines designed to heal such ailments are costly, and one cannot afford them for a large section of society.

Therefore, it becomes increasingly important to promote alternate generic medicines. Besides having a similar effect as the branded ones, they are pocket-friendly and thus accessible for the masses. However, some pharma companies are producing low-quality generics to earn greater profits. This imposes a severe threat to the health of the patients and questions the integrity of the Pharma Community.

JoinHub Pharma separates itself from the rest of the pharma companies with its safe and genuine generic medicines. We maintain appropriate collaboration with the doctors and pharmacists to keep upgrading the manufactured pharma products. We understand that even a minor change in composition can hugely affect human lives. Our ultimate goal is to make high-quality generic medicines available at an affordable rate not only for Latin America but for the entire globe.

If you’re looking for a reliable pharmaceutical exporter from India with competitive pricing, please contact us for further information. You will be amazed by our reasonable prices & efficient service. Simply drop us an email at [email protected], and our experts will reach out to you within 24 hours.

Generic Medicine Suppliers
Generic Medicine

Generic Medicine Suppliers Serving as World’s Pharmacy

The need of India to produce a huge amount of generic drugs perfectly lines up with its aim to become the most promising bulk, generic drug exporter, to markets of Africa, Qatar, Thailand, etc. Giving importance to this context, the nation has to embrace the economy and focus on producing bulk drugs to give the toughest competition to China and other countries. The government and the private generic medicine supplier are adopting distinct policy measures to generate new formulations and export bulk drugs.

Pharmaceutical as a component:

The trade expansion strategy of India considers pharmaceutical as a key component. The country has an objective in respect to the wider diversification of the medicine export profile given consideration to destination and products.

The global demand of exporting drugs has risen and so the nation is pushing its focus mainly on pharmaceuticals. By 2030, the pharma industry of India is hoping to become the largest drug supplier of the world. The target is to touch a revenue of approximately $120-130 billion at c CAGR of 11-12%. Presently, it is $38 billion.

Posing as world’s pharmacy:

Experts opine that this nation is posing as the world’s pharmacy due to the supply of low priced high-quality drugs in different countries. Medicine exporters in Qatar and other locations order drugs in bulk on a regular basis. The estimation of the government says that India proudly holds the 3rd rank globally for the production of pharmaceutical products by volume. Also, it holds 13th rank in pharmaceutical production by value.

Pharmaceuticals exporters in Africa: Now

According to an estimation, Africa spends approximately $2 billion per year on the treatment of AIDS patients. The executive director of UNAIDS, Michel Sidibé opined that if India would not help, then Africa could not access the treatment of AIDS at $2 billion. Without the presence of India, the cost could reach around $150 billion which is excessively massive.

Additionally, pharmaceutical exporters in Africa or pharma manufacturer in Nigeria are considering tuberculosis and anti-malaria drugs from India. The cost is much less than the medicines supplied by European and US drug suppliers.

In 2015, pharmaceutical exporters in Africa took pharma products that worth around $4 billion. Each year, the generic drug market in Africa is growing at 25 to 30 per cent. The market depends mainly on importing generic drugs.  Hence, the small, mid and good Indian pharmaceutical companies are grabbing this golden opportunity to expand the size and revenue.

Many times, the small pharmaceutical producers in India cannot match the stringent standards imposed by the authorities of Europe and the US. But, it is not the case with Africa, Nigeria, Tanzania, Madagascar, Mozambique, etc. So, the pharmaceutical companies in Nigeria, Africa, and etc. export bulk generic drugs and other pharma products from Indian companies.

Advantage India:

  • Among the top importers of pharma products from India, Nigeria, Qatar, Africa, Thailand, South Africa, USA, Russia, etc. hold prominent name.
  • Right now, generic medicine suppliers in India export around 20 to 22 percent of global export volume.
  • The cost of manufacturing is lower than half of Europe and the entire USA.

Indian pharma manufacturers and suppliers are helping relatively poorer nations like Africa, Nigeria, etc. to deal with tuberculosis, malaria, HIV, and other diseases like presently COVID issues through generic medicines that are low cost. The pharma manufacture in Nigeria is considering India as the key support to get the drugs in bulk for their people.

Thailand pharmaceutical manufacturers seeking India’s support:

Thailand is also wishing to get India’s support in the medical fields like pharmaceutical products and generic drugs. The top pharmaceutical companies in Thailand want to close the big gap between demand and supply of medical devices and pharmaceutical products. It is a major tourist spot. Besides, people from all over the world take treatments from here. India can efficiently fulfil the demands.

Ending with:

Pharma companies in Thailand or top 20 pharmaceutical companies in Nigeria, or any pharma manufacturers and exporters from other nations like Qatar, Africa, and others are depending on India for taking international brand names and generic medicines manufactured in this country. Certain awarded, accredited and trusted firms are ruling this field since long. These firms are committed to offering quality products to global clients.

They act as the one-stop solution for the entire pharmaceutical requirements without any compromise in quality and consistency. The WHO: GMP certified manufacturing plants ensure the products’ quality. The medicine exporters in Qatar, Thailand, Africa and other countries can easily contact these Indian firms online and discuss their requirements and objective. The private sectors and government of these countries are taking initiatives to strengthen the bond with India and exchange help. The authentic Indian firms are providing full value for money at each stage of pharmaceutical production and supply.

generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

 

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

 

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

 

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

 

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Pharmaceutical Drugs
Generic Medicine Pharmaceutical Company

Do Generic Pharmaceutical Drugs Compromise on Quality?

Nowadays due to increased health problems, and high medicinal expenses people have started making a shift to generic drugs which are the same as brand-name drugs and offer almost equivalent medicinal properties. Generic pharmaceutical companies have never been as famous as branded and marketed drug companies. So people always have a question regarding are generic drugs as safe as their branded counterparts and are they effective in treatments for severe health implications.

Generic drugs are identical counterparts of branded drugs and medicines manufactured by large corporations. When the patent of any particular brand-name drug expires, other smaller pharmaceutical companies manufacture a generic version of it and sell it in the open market. Generic drugs are relatively cheaper as the companies producing it do not have to invest much time and money into the research and development stage. Because a formulation is already available, everything the company then needs is just to manufacture it and get it approved by the FDA.

How does the FDA approve Generic Medicines?
If a company wants to get its generic drug approved with the FDA’s stamp, it must manufacture a drug that can be seen as a bioequivalent of the brand-name drug previously available. The FDA allows drug manufacturers to make a change in the active ingredients of medicine for up to 20% but top generic pharmaceutical companies do not go to that extent in making changes in the drug’s composition.

Moreover, generic manufacturers also do not need to go under vigorous drug tests as the data available with the FDA for previously used brand-name drugs is used as a result. Hence generic drugs are mostly passed with smaller test cycles and datasets. This does not raise a question about the effectiveness of the drug. The FDA chooses this course just to ensure that the drugs reach the patients speedily in the market.

Are generic drugs less effective?
Generic medicines are as effective as their brand-name substitutes. The FDA ensures that every drug being sold in the market is safe and effective for its consumers whether it is a brand-name drug or a generic drug. As we know generic drugs have almost identical medical formulation and are made using the same active ingredients used in the making of branded drugs, generic drugs are hence the effective and alternative solution to most branded drugs.

Generic drugs are also tested and reviewed thoroughly almost as same as their branded counterparts; hence consumers should not be worried about the drug’s effectiveness. The FDA also saves and publishes information regarding generic drugs for almost all types of critical diseases. Some people also think that generic drugs are cheaper as they are made by smaller companies with limited on-site production facilities but in contrast, the FDA makes sure that a generic drug manufacturing unit complies with all the norms laid down by the FDA for manufacturing of medicines and drugs. It isn’t always that only smaller companies manufacture generic drugs and sell them in the market, but research shows that almost 50% of all generic drugs manufactured come from big branded companies as companies always thrive to make their medicines available to consumers on a large scale.

How to identify Generic Drugs?
Some laws suggest guidelines for generic drugs; any generic drug cannot be made to look the same as its branded counterpart. However, differentiating between a brand-name drug and a generic drug is never a big hassle. Manufacturers, to comply with the statutory guidelines laid down by the FDA and other institutions; develop generic drugs that vary in packaging, naming, colors, shapes, sizes, and many more different dimensions.

Is a Generic Drug available for every other Branded Drug?
Branded drugs have patent protection for 20 years, which provides relief to a company that no other manufacturer can make the same drug and sell it in the market. However when a patent for a branded drug has expired or is about to expire other manufacturers can get consent from the FDA and start manufacturing the drug under the prescribed guidelines for generic drug manufacturing. It is somehow difficult to find generic drugs for brand medications that have been in the market for less than 20 years, as it comes under patent protection. However, a similar medication can be found if needed.

The Market’s Boom for Generic Drugs

Today numerous ailments have drugs with their prices sky-rocketing by the passage of time. Several insurance providers now approve and pay their insurance holders for opting into generic drugs. Generic drugs have now gained a higher level of trust from people and people consider them an effective option to switch from branded medicines. This has helped the generic drugs market to grow on a rapid scale for the last few years.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-drugs
Generic Medicine Pharma Products

The Pros and Cons of Using Generic Drugs

According to the Food and Drug Administration (FDA), generic drugs are biologically equivalent to brand name drugs in dosage form, strength, safety, route of administration, quality, performance characteristics, and intended use. Basically, a generic drug is a copycat of a brand name medication (made after the patent from the brand name has ended). They’re likewise typically a more affordable solution.

Generic drugs seem to be getting more and more famous when it comes to significant brand name drugs, including many medications related to heart health like blood pressure and statins medication.

In fact, a record 86% of prescriptions dispensed in 2017 were for generic drugs versus brand-name drugs as per the IQVIA, one of the world’s largest contract research organizations.

Yet, exactly how safe is generic drugs when it comes to staying heart healthy? Let’s take a look at some of the pros and cons of generic medication below.

Pros:

    • Cheaper prices. The main reason so many people purchase generic drugs is that they are more cost-effective than brand name drugs. Brand name drugs require research and testing that take a lot of money and time, however, generic drugs only need to copy what as of now exists, saving them the cost and permitting the price to stay low.
    • Biologically speaking, generic drugs should satisfy precise guidelines so that the same amount of active ingredient is conveyed to the body simultaneously, and utilized by the body, in the same way as the brand name product.
    • FDA approved. The FDA sets severe guidelines and performs research on generic drugs to ensure that they are bioequivalent to the brand name.
    • Heart Healthy. As indicated by a recent study, generic heart medications show the same medical outcomes as brand name medications.

Cons:

    • Contamination. Generic drugs are frequently produced in factories in countries like China, India, or other areas with cheap labor and overhead. The conditions at these manufacturing plants have sometimes contaminated drugs, leading to recalls in the United States. To be reasonable, however, there have been a handful of situations where even US-based brand name drugs had similar issues although probably not nearly as frequently.
    • As per the report by the Government Accountability Office, these foreign factories sometimes escape rigorous FDA inspections, dodge documentation of their practices, and don’t get follow-up monitoring even when genuine manufacturing or drug-handling problems have been recognized. Generally, only one manufacturer produces a brand name drug whereas a couple of manufacturers can produce a generic drug. While the FDA insists on the bioequivalence of the active medication, there sometimes can be unpretentious differences in the delivery system of the drug or non-active “fillers” for the drug. These distinctions rarely result in any clinically significant issue for the patient despite the fact that in rare cases a patient might have a sensitivity or intolerance to an alternate filler or delivery system.
    • Mixing up the pills. As brand medications ordinarily have a consistent “branded” look to them that patients can get familiar and comfortable with, generics frequently don’t look as familiar or it isn’t as obvious what each pill seems to be. Moreover, when a prescription is refilled, if the drug is made by a different generic manufacturer and has a different appearance, this can prompt drug confusion and blunders or even patients not taking the pills they are recommended.
    • Doctors remain divided. Many medical experts are still divided on the utilization of generic drugs for heart disease, leaving some lingering doubt in this area. Some particular medications including thyroid supplements and blood thinners have had evidence of genuine clinically meaningful issues when switching between brand and generic or between different generics.

More and more frequently patients discover their brand name prescription medication won’t be covered by their insurance plan or their co-pay is higher. Regularly, the insurer will offer a generic version at a co-pay that is less. Luckily, at this point, the vast majority of cardiac medications are accessible in the generic form with commonly no obvious problems for the vast majority of patients.

When patients start on a new medication that is easily available from a generic drug manufacturer, it is usually recommended starting with the generic form if there is no scientific agreement that the brand name version is any better. While usually, the patient will likewise save money directly, we all benefit from the total reduction in health care costs. If a patient has been on a brand medication and can save cash by adopting the generic formulation or even a more affordable brand of the same drug class, it typically should be possible without any ill effects but we believe it ultimately ought to be the patient’s choice after consulting with their physicians. Many patients prefer not to “rock the boat” and not make the switch. While that is not unreasonable, one needs to weigh whether it is worth the additional expense.

If you have any questions or concerns about taking a generic versus a brand-name medication, reach out to us at JoinHub Pharma.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-or-organic
Generic Medicine Pharma Products

The Mysteries Between The Branded Drugs Vs The Generic Drugs

Branded drugs are manufactured by an organization and are always sold under a brand name. Patents for such kinds of drugs can be obtained by including different inactive components to the drug, for example, flavoring and coloring agents.

Generic drugs are similar to branded drugs, yet they contain only the active components that are important to be included for the drug to be effective. Generic drugs don’t contain unnecessary inactive elements as branded drugs do. Generic drugs can be sold in the market once the branded drugs’ patents have lapsed, which is typically around 20 twenty years from the date of patent approval.

The Indian Pharma Market

India is perhaps the largest manufacturer of generic drugs globally. The Indian pharmaceutical sector industry supplies more than half of the global demand for different kinds of vaccinations. India holds a considerable position in the global pharmaceutical market as a supplier. The nation also consists of a large pool of scientists and engineers with the potential required to level the pharma industry up to a higher standard.

The Indian pharmaceutical market is foreseen to obtain the 9th position in the global market by 2023, thanks to different top-tier pharmaceutical companies that produce branded drugs that are sold highly in the market compared to generic drugs. Examples of some popular pharmaceutical companies include:

  • Sun Pharmaceutical Industries Limited
  • JoinHub Pharma
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Cipla Limited
  • Reddy’s Laboratories
  • Cadila Healthcare Limited
  • Intas Pharmaceuticals Limited

 

The Role of the FDA

The Food and Drug Administration department is actively taking part in the promotion of generic drugs worldwide, as it increases the availability of medicine at cheap prices.

Before launching a generic medicine in the market, the medicine must be approved by the FDA, who meticulously reviews the product and additionally guarantees that the drug meets certain standards applied for the approval of a branded drug. The department finds various steps to guarantee the safety and quality of drugs before and after it is launched in the market.

Even after the approval of any generic drug, the FDA keeps on observing the medicine’s level of safety to make sure that the products being sold to consumers are effective, safe, and of high quality. Thus, the FDA plays a significant part in offering quality medicine to those who require it, anywhere around the globe.

 

Difference between branded drugs and generic drugs

  • Branded drugs and generic drugs have similar active ingredients that are needed for the drug to be effective in nullifying the health condition. Branded and generic drugs are likewise similar when it comes to intake dosages and their strengths, with virtually no difference in their outcomes.
  • Branded drugs differ a lot from generic drugs in terms of size, shape, and color – this is generally done to facilitate patent approval, which needs a significant amount of distinction from existing drugs with comparative chemical compositions.
  • They are likewise discovered to have different inactive ingredients – branded drugs are heavy in content unrelated to the working of the drug, such as coloring and flavoring agents, on the other hand, generic drugs don’t include the utilization of gustatory and visual stimulation.
  • They are different in shapes, sizes, and colors.
  • They have different inactive ingredients. Most often only branded drugs have inactive components.
  • Generic drugs are more affordable than branded drugs.
  • Branded drugs are sold under a company’s name whereas generic drugs do not.

 

Clarifications:

Generic medication typically costs about 80% to 85% less than branded drugs. Generic drugs are less expensive because the manufacturer doesn’t have to develop and market a new drug, nor go through the troubles of researching, licensing, and getting it approved. It does not contain inactive components that are added to make them smell, look, and taste better, clearly leading to less expensive production costs.

  • Are generic drugs safe?

Indeed, Generic drugs are totally safe, as they are highly regulated and experience a rigorous review process before they are approved in the market. The Food and Drug Administration (FDA) tests the generic drugs to ensure that the drug is safe to be utilized by those afflicted with the disease being battled. The FDA only approves drugs if they meet all the guidelines for safe usage. After drug approval, the FDA will frequently inspect the manufacturing plant where the drug is manufactured and will monitor the drug for any safety concerns.

  • Why do branded drugs and generic drugs look different?

The shape, size, and color of the generic drugs and the branded drugs make them look unique.

 

Conclusion

It is apparent that Indian generic drug companies are growing at a fast pace. India is the biggest manufacturer of generic drugs in the world and thereby it helps to strengthen India’s burgeoning economy. A survey submitted by Global Business Report has stated that India’s pharma exports have increased by 11% in 2019, which is quite satisfactory. However, the popularity and demand for branded drugs in the market overpowers the presence of generic drugs.

Expensive branded medicines available in the market cannot be affordable by everyone. So, the Drug Price Control Order (DPCO) has decreased the price of some branded drugs. Regardless of this price reduction, a couple of branded drugs are still selling at high rates. Thus, the best alternative to these expensive branded drugs is generic drugs. The government must promote and advertise generic drugs to make them available to everyone. People should also start adopting generic medicines. Giving more into generic drugs will help them establish a strong presence in the market, which when combined with their cheap prices, will be the traction they require in the limit of pharmaceutical economies worldwide.

Get in touch with our experts at JoinHub Pharma today to know the pricing model of generic drugs.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK